What is the address of KCI Polymedics?

The registered office of KCI Polymedics is located at Ambachtslaan 1031, 3990 Peer.

Is KCI Polymedics still active?

Yes. According to the CBE (30 October 2026) KCI Polymedics is active, legal situation “Normale toestand”, started on 26 May 1994.

Is KCI Polymedics registered on Peppol?

Yes, KCI Polymedics is registered on the Peppol network with ID 0208:0452683261.

What is the enterprise number of KCI Polymedics?

The enterprise number of KCI Polymedics is BE0452683261.

When was KCI Polymedics founded?

KCI Polymedics was founded on 26 May 1994.

Is KCI Polymedics a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 May 1994; 5 annual accounts filed, latest fiscal year 2025; 5 directors known from the annual account.

How much profit did KCI Polymedics make in 2025?

KCI Polymedics posted a profit after taxes of € 291,948 in financial year 2025.

What is the revenue of KCI Polymedics?

As a small company, KCI Polymedics is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 2,224,583.

How much does an employee at KCI Polymedics earn?

The average wage cost per full-time employee at KCI Polymedics was € 97,400 in 2025: staff costs of € 1.6 million for 16.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does KCI Polymedics have?

According to the 2025 annual accounts, KCI Polymedics has 16.3 full-time equivalents (FTE).

KCI Polymedics (Private Limited) - Peer - BE0452683261

Q: What does KCI Polymedics do?

KCI Polymedics is registered with the CBE as active in: Vervaardiging van overige farmaceutische producten. Private Limited, started on 26 May 1994, 1 establishment.

Q: Who are the directors of KCI Polymedics?

According to the 2025 annual accounts, the directors of KCI Polymedics are: GERLINDE DE MEULENAER, JEAN-LUC VANDERLINDEN, CAGATAY GULER, Haluk Yilmaz, DEBBY POLET.

Dossier KCI Polymedics, printed on 30 October 2026 from databakkes.be/en/0452683261/kci-polymedics. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

KCI Polymedics from Peer, company number BE0452683261, closed financial year 2025 with a result of € 291,948 after tax. For that financial year KCI Polymedics recorded a gross margin of € 2.2 million and equity of € 4.6 million. Compared with financial year 2024, the result moved from € 258,684 to € 291,948. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 3, 2026.

What it is worth Growing

€ 4.6 million

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 291,948

▲ 13% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 740,593

▼ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 4.5 million.

People and assets in 2025

Full-time equivalents

16.3

▲ 0.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 1.6 million

▲ 6% vs 2024

€ 97,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 166,625

▼ 37% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 276,640

▲ 36% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 1,688,417 Gross margin 2022: € 1,688,417 First fiscal year in the series	€ 2,113,201 Gross margin 2023: € 2,113,201 ▲ 25% vs 2022 (€ 1,688,417) Favourable step	€ 2,072,827 Gross margin 2024: € 2,072,827 ▼ 2% vs 2023 (€ 2,113,201) Unfavourable step	€ 2,224,583 Gross margin 2025: € 2,224,583 ▲ 7% vs 2024 (€ 2,072,827) Favourable step	▲ 7%
Profit after taxes	€ 132,540 Profit after taxes 2022: € 132,540 First fiscal year in the series	€ 270,775 Profit after taxes 2023: € 270,775 ▲ 104% vs 2022 (€ 132,540) Favourable step	€ 258,684 Profit after taxes 2024: € 258,684 ▼ 4% vs 2023 (€ 270,775) Unfavourable step	€ 291,948 Profit after taxes 2025: € 291,948 ▲ 13% vs 2024 (€ 258,684) Favourable step	▲ 13%
Equity	€ 3,747,769 Equity 2022: € 3,747,769 First fiscal year in the series	€ 4,018,544 Equity 2023: € 4,018,544 ▲ 7% vs 2022 (€ 3,747,769) Favourable step	€ 4,277,227 Equity 2024: € 4,277,227 ▲ 6% vs 2023 (€ 4,018,544) Favourable step	€ 4,569,175 Equity 2025: € 4,569,175 ▲ 7% vs 2024 (€ 4,277,227) Favourable step	▲ 7%
Total debts	€ 471,336 Total debts 2022: € 471,336 First fiscal year in the series	€ 440,952 Total debts 2023: € 440,952 ▼ 6% vs 2022 (€ 471,336) Favourable step	€ 469,240 Total debts 2024: € 469,240 ▲ 6% vs 2023 (€ 440,952) Unfavourable step	€ 465,265 Total debts 2025: € 465,265 ▼ 1% vs 2024 (€ 469,240) Favourable step	▼ 1%
Cash	€ 833,210 Cash 2022: € 833,210 First fiscal year in the series	€ 806,716 Cash 2023: € 806,716 ▼ 3% vs 2022 (€ 833,210) Unfavourable step	€ 750,032 Cash 2024: € 750,032 ▼ 7% vs 2023 (€ 806,716) Unfavourable step	€ 740,593 Cash 2025: € 740,593 ▼ 1% vs 2024 (€ 750,032) Unfavourable step	▼ 1%
Retained profit	€ 3,685,769 Retained profit 2022: € 3,685,769 First fiscal year in the series	€ 3,956,544 Retained profit 2023: € 3,956,544 ▲ 7% vs 2022 (€ 3,685,769) Favourable step	€ 4,215,227 Retained profit 2024: € 4,215,227 ▲ 7% vs 2023 (€ 3,956,544) Favourable step	€ 4,507,175 Retained profit 2025: € 4,507,175 ▲ 7% vs 2024 (€ 4,215,227) Favourable step	▲ 7%
Balance sheet total	€ 4,219,106 Balance sheet total 2022: € 4,219,106 First fiscal year in the series	€ 4,459,495 Balance sheet total 2023: € 4,459,495 ▲ 6% vs 2022 (€ 4,219,106) Unchanged	€ 4,746,467 Balance sheet total 2024: € 4,746,467 ▲ 6% vs 2023 (€ 4,459,495) Unchanged	€ 5,034,440 Balance sheet total 2025: € 5,034,440 ▲ 6% vs 2024 (€ 4,746,467) Unchanged	▲ 6%
Employees (FTE)	12.9 Employees (FTE) 2022: 12.9 First fiscal year in the series	15.2 Employees (FTE) 2023: 15.2 ▲ 2.3 vs 2022 (12.9) Unchanged	16.1 Employees (FTE) 2024: 16.1 ▲ 0.9 vs 2023 (15.2) Unchanged	16.3 Employees (FTE) 2025: 16.3 ▲ 0.2 vs 2024 (16.1) Unchanged	▲ 0.2

Key figures of KCI Polymedics, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to KCI Polymedics?

What happened at KCI Polymedics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 3, 2026 New annual accounts for financial year 2025: profit of € 291,948 (▲ 13% vs 2024). Source: NBB ↗
2025 JEAN-LUC VANDERLINDEN became a director. NBB
2025 DEBBY POLET stepped down as director. NBB
2025 GERLINDE DE MEULENAER became a director. NBB
2025 Haluk Yilmaz stepped down as director. NBB
2024 CAGATAY GULER became a director. NBB
2024 Haluk Yilmaz became a director. NBB
2024 DEBBY POLET became a director. NBB

In short

From € 132,540 profit in 2022 to € 291,948 profit in 2025.

Paid € 366,069 in corporate taxes since 2022.

Best year ever: 2025, with € 291,948 profit.

On average € 136,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

BELGIUM KCI MEDICAL 100%

KCI MEDICAL BELGIUM 100%

The stake of KCI MEDICAL BELGIUM comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

KCI Polymedics

Behind KCI Polymedics are GERLINDE DE MEULENAER, JEAN-LUC VANDERLINDEN and CAGATAY GULER. The shares are held by BELGIUM KCI MEDICAL (100%) and KCI MEDICAL BELGIUM (100%).

Directors

According to the 2025 annual accounts

GERLINDE DE MEULENAER

Director

Also active at: KCI MEDICAL BELGIUM, TANDEM BE

since 2025

JEAN-LUC VANDERLINDEN

Director

Also active at: LORREINEN

since 2025

CAGATAY GULER

Director

since 2024

Haluk Yilmaz

Director

since 2024 · until 2025

DEBBY POLET

Director

since 2024 · until 2025

Shareholders

BELGIUM KCI MEDICAL

100%

KCI MEDICAL BELGIUM

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Ambachtslaan 1031

3990 Peer

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

KCI MEDICAL BELGIUM same network

€ 79.1 million revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0452.683.261

VAT number

BE 0452.683.261

Registered office

Ambachtslaan 1031, 3990 Peer

Names & denominations

KCI Polymedics

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

26 May 1994

Peppol

Active · Active since 17 Jul 2026

Activities · NACE

Vervaardiging van overige farmaceutische producten

Vervaardiging van overige farmaceutische preparaten

Vervaardiging van overige chemische producten

Vervaardiging van andere chemische producten, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

KCI Polymedics

Financials

What happened to KCI Polymedics?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions